BN Business News
Aggiungi la tua azienda →
Questa traduzione è in preparazione. Nel frattempo mostriamo temporaneamente la versione originale in inglese.

Regolamentazione e diritto · 04/12/19951 min di lettura

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Encapsulated High- Concentration Lipid A Composition as Immunogenic Agents

Traduzione automatica locale · Lingua originale della fonte

Riepilogo

In accordance with 37 CFR 404.6, announcement is made of the availability of U.S. Patent Application Serial No. 07/601,090 filed October 22, 1990 and entitled ``Encapsulated High-Concentration Lipid A Compositions as Immunogenic Agents to Produce Human Antibodies to Prevent or Treat Gram-Negative Bacterial Infections''. This Notice also announces the withdrawal of the intent to grant exclusive patent license to Univax Biologics, Inc. as indicated in the Federal Register, Volume 57, Number 99, page 21648 (May 21, 1992). This patent has been assigned to the United States Government as represented by the Secretary of the Army.

Lingua originale della fonte: Federal Register — All DocumentsApri il comunicato originale →

Esplora gli approfondimenti

Analisi aziendali →